Itamar Raz

Summary

Country: Israel

Publications

  1. pmc Present and future: pharmacologic treatment of obesity
    Mariela Glandt
    Department of Endocrinology, Bronx Lebanon Hospital Center, Bronx, NY 10457, USA
    J Obes 2011:636181. 2011
  2. ncbi request reprint Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal
    Paolo Pozzilli
    Corresponding author Itamar Raz
    Diabetes Care 37:1384-91. 2014
  3. ncbi request reprint Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial
    Itamar Raz
    Corresponding author Itamar Raz
    Diabetes Care 37:1392-400. 2014
  4. doi request reprint Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms
    Itamar Raz
    Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel
    Diabetes Metab Res Rev 28:321-4. 2012
  5. pmc The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issue
    Itamar Raz
    Diabetes Unit, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel
    Rev Diabet Stud 8:288-92. 2011
  6. pmc Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)
    Itamar Raz
    Diabetes Unit, Department of Internal Medicine, Hadassah Ein Kerem Hospital, Jerusalem, Israel
    Diabetes Care 35:485-7. 2012
  7. ncbi request reprint Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study
    Itamar Raz
    Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Clin Ther 27:1432-43. 2005
  8. doi request reprint Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion
    Itamar Raz
    The Diabetes Center, Hadassah Hebrew University School of Medicine, Jerusalem, Israel
    Clin Ther 31:980-7. 2009
  9. ncbi request reprint Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage
    Itamar Raz
    Department of Medicine, Diabetes Center, Hadassah University Hospital, Jerusalem 91120, Israel
    Diabetes Metab Res Rev 21:3-14. 2005
  10. ncbi request reprint Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy
    Itamar Raz
    Hadassah Ein Karem Medical Center, Jerusalem, Israel
    Clin Ther 25:3109-23. 2003

Detail Information

Publications57

  1. pmc Present and future: pharmacologic treatment of obesity
    Mariela Glandt
    Department of Endocrinology, Bronx Lebanon Hospital Center, Bronx, NY 10457, USA
    J Obes 2011:636181. 2011
    ..This paper reviews those medications which are available for treatment of obesity, including many of those recently taken off the market. It also discusses some of the newer treatments that are currently being investigated...
  2. ncbi request reprint Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal
    Paolo Pozzilli
    Corresponding author Itamar Raz
    Diabetes Care 37:1384-91. 2014
    ..This study compares these two stimulation methods using long-term data from patients newly diagnosed with type 1 diabetes or with latent autoimmune diabetes...
  3. ncbi request reprint Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial
    Itamar Raz
    Corresponding author Itamar Raz
    Diabetes Care 37:1392-400. 2014
    ..To evaluate safety and efficacy of DiaPep277 in preserving β-cell function in type 1 diabetic patients...
  4. doi request reprint Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms
    Itamar Raz
    Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel
    Diabetes Metab Res Rev 28:321-4. 2012
    ..Adherence to strict scientific methodology, ongoing large clinical trials and creating adjudicated patient databases may facilitate early recognition of adverse effects while avoiding disruptive false alarms...
  5. pmc The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issue
    Itamar Raz
    Diabetes Unit, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel
    Rev Diabet Stud 8:288-92. 2011
    ..We conclude that further drug development and clinical trials are required to overcome these limitations, and to counteract the movement towards higher incidence rates of T2D and its complications...
  6. pmc Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)
    Itamar Raz
    Diabetes Unit, Department of Internal Medicine, Hadassah Ein Kerem Hospital, Jerusalem, Israel
    Diabetes Care 35:485-7. 2012
    ..To evaluate the efficacy and safety of taspoglutide monotherapy in drug-naive patients with type 2 diabetes inadequately controlled...
  7. ncbi request reprint Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study
    Itamar Raz
    Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Clin Ther 27:1432-43. 2005
    ..Few large randomized controlled trials have assessed the value of adding insulin to an oral antidiabetic drug regimen...
  8. doi request reprint Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion
    Itamar Raz
    The Diabetes Center, Hadassah Hebrew University School of Medicine, Jerusalem, Israel
    Clin Ther 31:980-7. 2009
    ..InsuPatch (InsuLine Medical Ltd., Petach-Tikva, Israel) is a device intended to accelerate subcutaneous insulin delivery using an insulin pump by locally warming the infusion site...
  9. ncbi request reprint Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage
    Itamar Raz
    Department of Medicine, Diabetes Center, Hadassah University Hospital, Jerusalem 91120, Israel
    Diabetes Metab Res Rev 21:3-14. 2005
    ..Among surgical procedures, gastric bypass has been proven to produce beneficial results in advance of other surgical techniques, the evidence basis of which still needs strengthening...
  10. ncbi request reprint Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy
    Itamar Raz
    Hadassah Ein Karem Medical Center, Jerusalem, Israel
    Clin Ther 25:3109-23. 2003
    ..The incidence of type 2 diabetes mellitus (DM) is rapidly increasing worldwide. Results from large-scale studies show that tight blood glucose (BG) control improves the outcome of patients with type 2 DM...
  11. pmc Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications
    Jeanette Feder
    Department of Life Sciences and National Institute of Biotechnology in the Negev, Ben Gurion University of the Negev, Beer Sheva, Israel
    BMC Genomics 9:198. 2008
    ..Nevertheless these large-scale population screens often overlook the tremendous variation in the mitochondrial genome (mtDNA) and its involvement in complex disorders...
  12. ncbi request reprint Dose-response relationship of oral insulin spray in healthy subjects
    Simona Cernea
    Diabetes Unit, Dept of Medicine, Hadassah Hospital, POB 12000, Jerusalem, Israel 91120
    Diabetes Care 28:1353-7. 2005
    ..To evaluate the pharmacodynamic and pharmacokinetic properties and the dose-ranging effects of an oral insulin spray in comparison with subcutaneous regular insulin...
  13. doi request reprint Role of protein kinase C in the expression of endothelin converting enzyme-1
    Mogher Khamaisi
    Department of Medicine, Diabetes Research Unit, Hadassah Hospital, Ein Kerem, Mt Scopus, and the Hebrew University Medical School, Jerusalem, Israel
    Endocrinology 150:1440-9. 2009
    ..These results show that enhanced ECE-1 expression induced by hyperglycemia is partly due to activation of the PKC-delta isoform. Thus, inhibition of this PKC isoform may prevent diabetes-related increase in ET-1...
  14. ncbi request reprint Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study
    Simona Cernea
    Diabetes Unit, Internal Medicine Department, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Clin Ther 27:1562-70. 2005
    ....
  15. ncbi request reprint Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
    Itamar Raz
    Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Curr Med Res Opin 24:537-50. 2008
    ..The purpose of this study was to evaluate the efficacy and safety of sitagliptin as an add-on to metformin therapy in patients with moderately severe (hemoglobin A(1c) >or= 8.0% and <or= 11.0%) type 2 diabetes mellitus (T2DM)...
  16. ncbi request reprint Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes
    Mogher Khamaisi
    Department of Internal Medicine B, Diabetes Center, Hadassah University Hospital, Jerusalem, Israel
    Nephron Physiol 102:p72-80. 2006
    ..To evaluate the role of NO in developing diabetic kidney disease, we studied the NO system in streptozotocin (STZ)-induced diabetic rats for a period of 8 weeks...
  17. ncbi request reprint Role of insulin and the IGF system in renal hypertrophy in diabetic Psammomys obesus (sand rat)
    Itamar Raz
    Diabetes Center and Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel
    Nephrol Dial Transplant 18:1293-8. 2003
    ....
  18. ncbi request reprint IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide
    Sarah Weksler-Zangen
    Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Am J Physiol Endocrinol Metab 306:E648-57. 2014
    ..We suggest that islet COX activity must be maintained above a critical threshold to sustain adequate GSIS with exposure to low-copper HSD. ..
  19. pmc Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial
    Itamar Raz
    Internal Medicine, Hadassah Hospital, Jerusalem, Israel
    Diabetes Care 32:381-6. 2009
    ....
  20. pmc Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients
    Meir Mizrahi
    Department of Medicine, Liver Unit, Hebrew University Hadassah Medical Center Ein Karem, Jerusalem 12000, Israel
    Nutr J 9:25. 2010
    ..The BreathID system can continuously analyse breath samples in real-time at the point-of-care. Here we determined the efficacy of the BreathID using the 13C-Glucose breath test (GBT) for evaluation of insulin resistance...
  21. ncbi request reprint Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities
    Mogher Khamaisi
    Diabetes Center, Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel
    Isr Med Assoc J 5:801-6. 2003
    ....
  22. pmc Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemia
    Itamar Raz
    Department of Internal Medicine, Hadassah Hospital, Jerusalem, Israel
    Diabetes Care 34:1511-3. 2011
    ..To identify the Hyperglycemia and Its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (HEART2D) trial subgroups with treatment difference...
  23. doi request reprint Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results
    Roy Eldor
    Diabetes Research Center, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel
    Diabetes Metab Res Rev 25:316-20. 2009
    ....
  24. ncbi request reprint In-hospital treatment of hyperglycemia: effects of intensified subcutaneous insulin treatment
    Hila Elinav
    Endocrinology and Metabolism Service and the Hadassah Diabetes Center, Department of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Curr Med Res Opin 23:757-65. 2007
    ..No methods for achievement of proper glycemic control in this population have been validated in the in-hospital setting...
  25. doi request reprint Effects of moderate intensity glycemic control after cardiac surgery
    Gil Leibowitz
    Department of Medicine, Endocrinology and Metabolism Service and Hadassah Diabetes Center, Jerusalem, Israel
    Ann Thorac Surg 90:1825-32. 2010
    ..We used a protocol based on dynamic insulin administration targeted to achieve moderately tight glycemic control and tested its impact on clinical outcomes after cardiac surgery...
  26. pmc Effect of mild hypoinsulinemia on renal hypertrophy: growth hormone/insulin-like growth factor I system in mild streptozotocin diabetes
    Mogher Khamaisi
    Diabetes Center and Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel
    Int J Exp Diabetes Res 3:257-64. 2002
    ....
  27. ncbi request reprint Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT
    Muhammad A Abdul-Ghani
    Department of Diabetes, Lin Medical Center, Clalit Health Services, Haifa and Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel
    Diabetes Metab Res Rev 22:126-30. 2006
    ..Epidemiological studies demonstrated that the two categories define distinct populations. In this study, we examined the contributions of insulin resistance and beta-cell dysfunction to both states in overweight subjects of Arab origin...
  28. ncbi request reprint The Controversies in Obesity, Diabetes and Hypertension (CODHy) meeting: what is it all about?
    Itamar Raz
    Diabetes Center, Hadassah Hebrew School of Medicine, Jerusalem, Israel
    Diabetes Care 31:S111-2. 2008
  29. ncbi request reprint Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique
    Simona Cernea
    Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, PO Box 12000, Jerusalem 91120, Israel
    Clin Ther 26:2084-91. 2004
    ..This system delivers an aerosol of uniform-sized droplets containing regular human insulin at a high velocity into the oropharyngeal cavity for local transmucosal absorption...
  30. ncbi request reprint Early use of insulin in type 2 diabetes
    Roy Eldor
    Diabetes Research Center, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel
    Diabetes Res Clin Pract 68:S30-5. 2005
    ..This new approach, its rationale, benefits and misgivings are discussed in this review...
  31. ncbi request reprint Noninjectable methods of insulin administration
    Simona Cernea
    Division of Endocrinology, Department of Medicine, Columbia University, New York, New York, USA
    Timely Top Med Cardiovasc Dis 10:E29. 2006
    ..Sanofi-Aventis Group) has already become clinically available in the United States and Europe for patients with diabetes. Other noninjectable methods of insulin administration are reviewed...
  32. ncbi request reprint Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus
    Roy Eldor
    Diabetes Research Center, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Int Rev Immunol 24:327-39. 2005
    ..Here we review the most promising therapies developed based on these targets and emphasize those that have reached human phase clinical investigation...
  33. ncbi request reprint Association of hyperglycemia and insulin with diabetic cardiovascular complications
    Mogher Khamaisi
    Diabetes Center, Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel
    Isr Med Assoc J 5:116-9. 2003
    ....
  34. ncbi request reprint Noninjectable methods of insulin administration
    Simona Cernea
    Division of Endocrinology, Department of Medicine, Columbia University, New York, New York, USA
    Drugs Today (Barc) 42:405-24. 2006
    ..Sanofi-Aventis Group) has already become clinically available in the United States and Europe for patients with diabetes. Other noninjectable methods of insulin administration are reviewed...
  35. ncbi request reprint Increased expression of endothelin-converting enzyme-1c isoform in response to high glucose levels in endothelial cells
    Shoshana Keynan
    Diabetes Center and Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel
    J Vasc Res 41:131-40. 2004
    ..The main isoform to increase in response to high glucose was ECE-1c. This enzyme may be one of the factors contributing to the elevated ET-1 peptide levels observed in diabetes...
  36. ncbi request reprint Noninvasive continuous glucose monitoring using photoacoustic technology-results from the first 62 subjects
    Ram Weiss
    The Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Diabetes Technol Ther 9:68-74. 2007
    ..Continuous glucose monitoring is a useful tool for the achievement of improved glucose control in patients with diabetes. We tested the ability of a novel noninvasive continuous glucose monitor to track glucose excursions...
  37. pmc Effect of short-term hyperglycemia on protein kinase C alpha activation in human erythrocytes
    Leonid Livshits
    The Diabetes Research Center, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Rev Diabet Stud 9:94-103. 2012
    ..Protein kinase C alpha (PKCα) is a major regulator of many metabolic processes and structural changes in erythrocytes, and may play a significant role in the development of hyperglycemia-mediated cellular abnormalities...
  38. doi request reprint Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues
    Roy Eldor
    Division of Diabetes and The Endocrinology Service, Department of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Diabetes Metab Res Rev 28:85-9. 2012
    ..It is important to emphasize that regardless of it being a review of published evidence, it primarily represents the professional opinion of the writers...
  39. doi request reprint Glucose tolerance factor extracted from yeast: oral insulin-mimetic and insulin-potentiating agent: in vivo and in vitro studies
    Sarah Weksler-Zangen
    The Diabetes Unit, Department of Internal Medicine and The Hadassah Diabetes Center, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Br J Nutr 108:875-82. 2012
    ..It produces an insulin-like effect by acting on cellular signals downstream of the insulin receptor. These results demonstrate a potential source for a novel oral medication for diabetes...
  40. ncbi request reprint Immune modulation for prevention of type 1 diabetes mellitus
    Itamar Raz
    Diabetes Research Center, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel
    Trends Biotechnol 23:128-34. 2005
    ..Here, we review the results of these trials...
  41. pmc Cannabidiol arrests onset of autoimmune diabetes in NOD mice
    Lola Weiss
    Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel
    Neuropharmacology 54:244-9. 2008
    ..Our data strengthen our previous assumption that CBD, known to be safe in man, can possibly be used as a therapeutic agent for treatment of type 1 diabetes...
  42. ncbi request reprint Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect
    David Stepensky
    Department of Pharmaceutics, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel
    Drug Metab Dispos 30:861-8. 2002
    ....
  43. ncbi request reprint Reproducibility of glucose measurements using the glucose sensor
    Muriel Metzger
    Diabetes Center, Endocrinology and Metabolism Service, Hadassah University Hospital, Jerusalem, Israel
    Diabetes Care 25:1185-91. 2002
    ..Its use is currently limited to the health care team. Our aim was to evaluate the reproducibility of data provided by the device by comparing data provided by two sensors worn simultaneously by the same subject...
  44. doi request reprint Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women
    Auryan Szalat
    Department of Endocrinology and Metabolism, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Diabetes Obes Metab 10:1135-56. 2008
    ..These gender-specific features of DM may offer a route to improved care for women and new therapeutic possibilities...
  45. ncbi request reprint Insulin-induced hypertension, L-arginine, and endothelial nitric oxide synthase in pregnant rats
    Michael Bursztyn
    Department of Medicine, Hadassah University Hospital, Mount Scorpus, Jerusalem, Israel
    Hypertens Pregnancy 22:267-74. 2003
    ..8 +/- 2.3, p < 0.03. Thus, the salutary effect of l-arginine on hyperinsulinemic pregnancy-induced hypertension (PIH) may be mediated, in part, by endothelial nitric oxide synthase in their kidneys...
  46. ncbi request reprint Sitagliptin: a viewpoint by Itamar Raz
    Itamar Raz
    Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel
    Drugs 67:598-9. 2007
  47. ncbi request reprint Possible association between diabetes and bisphosphonate-related jaw osteonecrosis
    Mogher Khamaisi
    Department of Internal Medicine B and the Diabetes Center, Hebrew University Hadassah Medical Center, Kiryat Hadassah, P O Box 12000, Jerusalem 91120, Israel
    J Clin Endocrinol Metab 92:1172-5. 2007
    ..Bisphosphonate-related osteonecrosis (BON) of the jaws is a newly identified condition for which the exact mechanism involved in its pathogenesis remains obscure...
  48. ncbi request reprint The role of sulodexide in the treatment of diabetic nephropathy
    Ram Weiss
    Diabetes Center, Hadassah Hebrew University School of Medicine, Jerusalem, Israel
    Drugs 67:2681-96. 2007
    ....
  49. ncbi request reprint Focus on childhood fitness, not just fatness
    Ram Weiss
    Department of Pediatrics, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Lancet 368:261-2. 2006
  50. pmc Analysis: accuracy performance of the Medtronic NexSensor for 6 days in an inpatient setting using abdomen and buttocks insertion sites
    Mariela Glandt
    Department of Internal Medicine, Bronx Lebanon Hospital, Bronx, New York 10457, USA
    J Diabetes Sci Technol 5:365-7. 2011
    ..As far as improved accuracy, the authors find evidence in favor of NexSensor as compared to Sof-Sensor, although this evidence is preliminary and is not backed by statistical significance measures...
  51. doi request reprint Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus
    Jacob A Udell
    TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Clin Cardiol 35:722-9. 2012
    ..In this review, we provide recommendations for the use of statins and aspirin for the prevention of cardiovascular events in high-risk patients with diabetes mellitus...
  52. pmc Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum
    Itamar Raz
    Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Diabetes Care 36:1779-88. 2013
    ....
  53. doi request reprint Emerging gliptins for type 2 diabetes
    Avivit Cahn
    Hadassah Hebrew University Medical Center, The Diabetes Research Center, Jerusalem, Israel
    Expert Opin Emerg Drugs 18:245-58. 2013
    ..The drugs are safe, weight neutral and widely prescribed. There are currently eight gliptins registered worldwide with several more in advanced stages of development...
  54. pmc The Individualized Target HbA1c: A New Method for Improving Macrovascular Risk and Glycemia Without Hypoglycemia and Weight Gain
    Roy Eldor
    Diabetes Research Center, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel
    Rev Diabet Stud 6:6-12. 2009
    ..Using our newly suggested system, a physician will first calculate the adequate HbA1c goal for his patient and then choose the drug that will best suit him, thus tailoring the treatment to the patients needs...
  55. ncbi request reprint Gender-specific care of diabetes
    Auryan Szalat
    Hadassah Hebrew University Hospital, Internal Medicine, Endocrinology and Metabolism, Jerusalem, Israel
    Womens Health (Lond Engl) 3:735-64. 2007
    ....